» Articles » PMID: 38338950

MiRNAs in Heart Development and Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 10
PMID 38338950
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases (CVD) are a group of disorders that affect the heart and blood vessels. They include conditions such as myocardial infarction, coronary artery disease, heart failure, arrhythmia, and congenital heart defects. CVDs are the leading cause of death worldwide. Therefore, new medical interventions that aim to prevent, treat, or manage CVDs are of prime importance. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the posttranscriptional level and play important roles in various biological processes, including cardiac development, function, and disease. Moreover, miRNAs can also act as biomarkers and therapeutic targets. In order to identify and characterize miRNAs and their target genes, scientists take advantage of computational tools such as bioinformatic algorithms, which can also assist in analyzing miRNA expression profiles, functions, and interactions in different cardiac conditions. Indeed, the combination of miRNA research and bioinformatic algorithms has opened new avenues for understanding and treating CVDs. In this review, we summarize the current knowledge on the roles of miRNAs in cardiac development and CVDs, discuss the challenges and opportunities, and provide some examples of recent bioinformatics for miRNA research in cardiovascular biology and medicine.

Citing Articles

X-Chromosome-Linked miRNAs Regulate Sex Differences in Cardiac Physiology.

Emerson J, Shi W, Paredes-Larios J, Walker W, Hutton J, Cristea I Circ Res. 2025; 136(3):258-275.

PMID: 39772608 PMC: 11781965. DOI: 10.1161/CIRCRESAHA.124.325447.


Exosomes and miRNAs in Cardiovascular Diseases and Transcatheter Pulmonary Valve Replacement: Advancements, Gaps and Perspectives.

Liang R, Abudurexiti N, Wu J, Ling J, Peng Z, Yuan H Int J Mol Sci. 2025; 25(24.

PMID: 39769447 PMC: 11727898. DOI: 10.3390/ijms252413686.


The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.

Crocco P, Montesanto A, La Grotta R, Paparazzo E, Soraci L, Dato S Int J Mol Sci. 2024; 25(23).

PMID: 39684483 PMC: 11641116. DOI: 10.3390/ijms252312772.


Binding-driven forward tearing protospacer activated CRISPR-Cas12a system and applications for microRNA detection.

Zhao L, Deng X, Li Y, Zhao Q, Xiao L, Xue J J Nanobiotechnology. 2024; 22(1):684.

PMID: 39516870 PMC: 11545271. DOI: 10.1186/s12951-024-02915-5.


Global research landscape on the genetics of congenital heart disease: A bibliometric and visualized analysis via VOSviewer and CiteSpace.

Zhang F, Qi L, Zhao M, Han S, Zhang H, Wang G Medicine (Baltimore). 2024; 103(43):e40261.

PMID: 39470501 PMC: 11521071. DOI: 10.1097/MD.0000000000040261.


References
1.
Chu B, Wu T, Miao L, Mei Y, Wu M . MiR-181a regulates lipid metabolism via IDH1. Sci Rep. 2015; 5:8801. PMC: 4350072. DOI: 10.1038/srep08801. View

2.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

3.
Wagh V, Pomorski A, Wilschut K, Piombo S, Bernstein H . MicroRNA-363 negatively regulates the left ventricular determining transcription factor HAND1 in human embryonic stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2014; 5(3):75. PMC: 4097848. DOI: 10.1186/scrt464. View

4.
Cheng Y, Tan N, Yang J, Liu X, Cao X, He P . A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010; 119(2):87-95. PMC: 3593815. DOI: 10.1042/CS20090645. View

5.
Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G . Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2018; 20(5):1836-1852. PMC: 7414524. DOI: 10.1093/bib/bby054. View